Patent · US Active

Antibodies specific for amyloid beta protofibril

US8409575B2 · kind B2 · utility

7Cited by

23References

12Claims

0Family size

Assignee

BioArctic Neruoscience AB · SE

Inventors

Lars Lannfelt · Stockholm, SE
Camilla Nilsberth · Söderhamn, SE
Anita Campbell · Trosa, SE
Jan Naslund · Bissenkamp, SE

Key dates

Filing date	Aug 26, 2011
Grant date	Apr 2, 2013
Priority date	—
Expiry date	Aug 26, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a purified antibody or fragment thereof that specifically binds an Aβ protofibril. The invention further relates to a composition that includes such antibodies. The invention also relates to using such antibodies and compositions for treating a patient having of suspected of having Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.